Literature DB >> 225437

SV40-related T-antigen expression in human meningiomas with normal and G-22-monosomic karyotype.

G May, H Fischer, K D Zang.   

Abstract

Six of 16 meningiomas tested in early subcultures by indirect immunofluorescence showed SV40 T-antigen. Two different antisera specific for T-antigen were used. One serum gave a positive reaction with six tumours and the other with only two. In one T-antigen positive meningioma, the typical nuclear fluorescence changed, beginning with the second subculture, into an unusual brilliant granular pattern irregularly distributed over the nuclei. In six meningiomas, a specific chromosome aberration (monosomy G 22) was established. However, up to now, no clear correlation between karyotype and T-antigen expression could be found: cells from three meningiomas with positive reactions had normal karyotypes, whereas those from three tumours with typical chromosome loss showed no T-antigen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225437     DOI: 10.1099/0022-1317-43-3-697

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

Review 1.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

2.  Karyotypic variations in human meningioma cell cultures under different in vitro conditions.

Authors:  H Zankl; B Ludwig; G May; K D Zang
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

3.  Fetal origin of the medulloblastoma: evidence from growth analysis of two cases.

Authors:  K Hirakawa; K Suzuki; S Ueda; J Handa
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Are human DNA tumour viruses involved in the pathogenesis of human neurogenic tumors?

Authors:  H Ibelgaufts
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

5.  Papovavirus-related RNA sequences in human neurogenic tumours.

Authors:  H Ibelgaufts; K W Jones
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.